WallStreetZenWallStreetZen

NASDAQ: SPRB
Spruce Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SPRB earnings and revenue history

Current Revenue
$10.1M
Current Earnings
-$47.9M
Current Profit Margin
-475%

SPRB Return on Equity

Current Company
-52.3%
Current Industry
-63.5%
Current Market
188%
SPRB's Return on Equity (-52.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SPRB announces earnings.

SPRB Return on Assets

Current Company
-39.8%
Current Industry
2.9%
SPRB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SPRB Return on Capital Employed

Current Company
-59.68%
Current Industry
19.5%
SPRB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SPRB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SPRB$10.09M-$47.14M-$47.92MN/AN/A
LEXX$386.00k-$5.24M-$5.45M+7.07%N/A
SRZN$0.00-$39.86M-$43.04M-100.00%N/A
IGC$1.22M-$13.52M-$14.15M-23.74%N/A
APRE$583.23k-$15.50M-$14.29MN/AN/A
View Top Biotech Stocks

SPRB earnings dates

Next earnings date
May 13, 2024

Spruce Biosciences Earnings & Revenue FAQ

What were SPRB's earnings last quarter?

On Invalid Date, Spruce Biosciences (NASDAQ: SPRB) reported Q4 2023 earnings per share (EPS) of -$0.23, up 51.06% year over year. Total Spruce Biosciences earnings for the quarter were -$9.95 million. In the same quarter last year, Spruce Biosciences's earnings per share (EPS) was -$0.47.

If you're new to stock investing, here's how to buy Spruce Biosciences stock.

What was SPRB's earnings growth in the past year?

As of Q2 2024, Spruce Biosciences's earnings has grown year over year. Spruce Biosciences's earnings in the past year totalled -$47.92 million.

What is SPRB's earnings date?

Spruce Biosciences's earnings date is Invalid Date. Add SPRB to your watchlist to be reminded of SPRB's next earnings announcement.

What was SPRB's revenue last quarter?

On Invalid Date, Spruce Biosciences (NASDAQ: SPRB) reported Q4 2023 revenue of $2.89 million up Infinity% year over year. In the same quarter last year, Spruce Biosciences's revenue was $0.00.

What was SPRB's revenue growth in the past year?

As of Q2 2024, Spruce Biosciences's revenue has grown null year over year. Spruce Biosciences's revenue in the past year totalled $10.09 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.